Journal of Korean Medicine Rehabilitation (한방재활의학과학회지)

The society of Korean Medicine Rehabilitation (한방재활의학과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Herbal Medicines on Bone Mineral Density Score in Osteoporosis or Osteopenia: Study Protocol for a Systematic Review and Meta-Analysis

한약이 골다공증 혹은 골감소증 환자의 골밀도에 미치는 영향: 체계적 문헌고찰 및 메타분석을 위한 프로토콜

  • Hong, Su Min (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Daejeon University) ;
  • Lee, Eun Jung (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Daejeon University)
  • 홍수민 (대전대학교 한의과대학 한방재활의학과교실) ;
  • 이은정 (대전대학교 한의과대학 한방재활의학과교실)
  • Received : 2021.03.26
  • Accepted : 2021.04.05
  • Published : 2021.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives The impact of social and economic losses on society due to the occurrence of osteoporosis patients is serious. The purpose of this study is to identify the types and effects of herbal medicine for osteoporosis and osteopenia. Methods We will investigate 8 online databases (MEDLINE/PubMed, Cochrane library, EMbase, China National Knowledge Infrastructure [CNKI], J-stage, National Digital Science Library [NDSL], Research Information Sharing Service [RISS], Koreanstudies Information Service System [KISS]) without language, publication date limitation for the clinical study of herbal medicine for osteoporosis and osteopenia published between the start of the database and 2021. The frequency, duration and pattern of the any type of herbal medicine utilization will be analyzed. Results Randomized controlled trials about herbal medicine or herbal medicine extracts for osteoporosis and osteopenia should be included in the study. Cochrane risk in bias tools will be used to evaluate the methodological quality of the study. A risk ratio or mean difference with a 95% confidence interval will show the effects of herbal medicine or herbal medicine extracts for osteoporosis and osteopenia. Conclusions The results of the systematic review will reflect the current status of herbal medicine treatment for osteoporosis and osteopenia, and it can be expected to verify the validity of the effectiveness, and provide it as a basic data for the use of herbal medicine in clinical utilization.

Keywords

References

  1. The Korean Orthopaedic Association. Orthopaedics. 7th ed. Seoul:ChoiSin medical Publishing Co. 2013:251-68.
  2. Korean Society for Bone and Mineral Research. Osteoporosis. 3rd ed. Seoul:Hanmi Medical Publishing. 2006:12.
  3. Kim SW, Chung YK. Longterm follow-up of osteoporotic vertebral fractures according to the morphologic analysis of fracture pattern. J Korean Soc Spine Surg. 2000;7:611-7.
  4. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285-9. https://doi.org/10.1007/BF01623184
  5. Korea National Statistical Office. Korea: key results of 2020 elderly statistics [Internet] 2020 [cited 2021 Mar 13]. Available from: URL: http://kostat.go.kr/portal/korea/kor_nw/1/1/index.board?bmode=read&aSeq=385322.
  6. Health Insurance Review & Assessment Service. Korea: statistics of national diseases of interest [Internet] 2020 [cited 2021 Mar 11]. Available from: URL: http://opendata.hira.or.kr/op/opc/olapMfrnIntrsIlnsInfo.do.
  7. Bank of Korea. Korea: national income statistics [Internet] 2017 [cited 2021 Mar 11]. Available from: URL: https://www.bok.or.kr/ebook/ecatalog5.jsp?Dir=276.
  8. Moon JS, Won KC. The diagnosis and treatment of osteoporosis. Yeungnam Univ J of Med. 2008;25(1):19-30. https://doi.org/10.12701/yujm.2008.25.1.19
  9. Kim YM, Kim TK, Shim DM, Lim KH. Treatment options of osteoporotic vertebral compression fractures. J Korean Fract Soc. 2018;31(3):114-21. https://doi.org/10.12671/jkfs.2018.31.3.114
  10. Rozenberg S, Kroll M, Pastijn A, Vandromme J. Osteoporosis prevention and treatment with sex hormone replacement therapy. Clinical Rheumatology. 1995;14(3):14-7.
  11. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New England Journal Clinical Rheumatology. 1995;332:1589-93.
  12. Devogelaer JP, Brown JP, Burckhardt P, Meunier PJ, Goemaere S, Lippuner K, Body JJ, Samsioe G, Felsenberg D, Fashola T, Sanna L, Ortmann CE, Trechsel U, Krasnow J, Eriksen EF, Garnero P. Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporos Int. 2007;18:1211-8. https://doi.org/10.1007/s00198-007-0367-3
  13. Kang SG, Park YB, An HS. The bibliographical studies on the acupuncture treatment of the osteoporosis. The Journal of Korean Acupuncture & Moxibustion Society. 1995;15(2):171-89.
  14. Kim JH, Kim JS. Effects of lycii fructus and lycii folium extracts on osteoporosis in ovariectomized rats. Journal Korean Soc Food Sci Nutr. 2014;43(1):24-9. https://doi.org/10.3746/JKFN.2014.43.1.024
  15. Kum CJ, Cho CY, Lim JM, Song DU, Kim JH, Lee B, Jung HS. Effects of Yoohyangheukho-dan (Ruxiangheihu-dan) on osteoporosis induced by ovariectomy in rats. J Korean Med Rehabil. 2014;24(3):29-37.
  16. Zhang ND, Han T, Huang BK, Rahman K, Jiang YP, Xu HT, Qin LP, Xin HL, Zhang QY, Li YM. Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery. Journal of Ethnopharmacology. 2016;189:61-80. https://doi.org/10.1016/j.jep.2016.05.025
  17. Jin YX, Wu P, Mao YF, Wang B, Zhang JF, Chen WL, Liu Z, Shi XL. Chinese herbal medicine for osteoporosis: a meta-analysis of randomized controlled trials. Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health. 2017;20(4):516-25. https://doi.org/10.1016/j.jocd.2017.07.003
  18. Fu FY, Sun JG, Wang RT, Ye HL, Tan B, Yan Y, Chen WH. Meta-analysis and medication analysis of TCM compound in the treatment of senile osteoporosis. Journal of Hainan Medical University. 2020;26(2):137-46.
  19. Kim SY, Park JE, Seo HJ, Lee YJ, Jang BH, Son HJ, Suh HS, Shin CM. NECA's guidance for undertaking systematic reviews and meta-analysis for intervention. 1st ed. Seoul:National Evidence-based Healthcare Collaborating Agency. 2011:24-5, 64-75.
  20. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser. 1994;843:1-129.
  21. Ambrish M, Beena B, Carey SK, Ebeling P. The Asia-Pacific regional audit-epidemiology, costs, and burden of osteoporosis in India 2013: a report of International Osteoporosis Foundation. Indian Journal of Endocrinology and Metabolism. 2014;18(8):449-54.

Cited by

  1. 골다공증 다빈도 처방과 구성 약물의 네트워크 분석 - 오아시스 검색을 중심으로 vol.42, pp.4, 2021, https://doi.org/10.22246/jikm.2021.42.4.628